The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...

All medicines have risks and benefits. Your doctor has weighed the risks of you taking ONDANSETRON ODT VIATRIS orally disintegrating tablets against the benefits this medicine is expected to have ...

Medically reviewed by Lindsay Cook, PharmD Ubrelvy (ubrogepant) and Nurtec (rimegepant) are prescription medications approved ...